Safety tolerability and acceptability of longacting injectable cabotegravir for HIV prevention in cisgender female adolescents HPTN 08401 a singlearm openlabel phase 2b trial

Simple item page
dc.article.end-page260en
dc.article.start-page252en
dc.citation.doi10.1016/S2352-3018(24)00310-2en
dc.contributor.authorLynda Stranix-Chibandaen
dc.contributor.authorErica L Hamiltonen
dc.contributor.authorJulie Ngoen
dc.contributor.authorYuqing Jiaoen
dc.contributor.authorAnn Delany-Moretlween
dc.contributor.authorIshana Naidooen
dc.contributor.authorE et alen
dc.date.accessioned2026-03-26T09:56:48Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2352-3018en
dc.identifier.urihttps://hdl.handle.net/10539/48720
dc.journal.titleSafety tolerability and acceptability of longacting injectable cabotegravir for HIV prevention in cisgender female adolescents HPTN 08401 a singlearm openlabel phase 2b trialen
dc.journal.volume12en
dc.titleSafety tolerability and acceptability of longacting injectable cabotegravir for HIV prevention in cisgender female adolescents HPTN 08401 a singlearm openlabel phase 2b trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
562.66 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)